Psychopharmacology in HIV spectrum disorders.
The psychiatric complications of HIV spectrum disorders are common and diverse in nature. HIV itself undermines the individual's psychological functioning by attacking the CNS and further compromises the patient's psychosocial and coping capacity. Psychopharmacologic strategies are vastly underutilized in the management of these psychiatric complications but often must be innovative, given the complexities of medical management in most of these cases. Conventional and innovative psychopharmacologic interventions when used as part of an integrated comprehensive biopsychosocial approach are effective adjuvants that help patients achieve the greatest functional adaptation possible.
Fernandez
F
F
Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas.
Levy
J K
JK
D015526:AIDS Dementia Complex / Q000188:drug therapy; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy / Q000209:etiology; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D002065:Buspirone / Q000008:administration & dosage / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D016651:Lithium Carbonate / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy* / Q000209:etiology; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D014196:Trazodone / Q000008:administration & dosage / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D008996:Monoamine Oxidase Inhibitors; D011619:Psychotropic Drugs; D001569:Benzodiazepines; D016651:Lithium Carbonate; D002065:Buspirone; D014196:Trazodone